Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New nursing strategy aims to cut ICU infections

NCT ID NCT07656363

Disease control Sponsor: The First Hospital of Qinhuangdao Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a bundle nursing intervention for ICU patients with devices like catheters or ventilators. The intervention combined targeted infection monitoring, teamwork, and specific care steps. Researchers compared infection rates, antibiotic use, and hospital stay between the intervention group and a group receiving routine care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bundle nursing intervention (targeted surveillance, multidisciplinary collaboration, and care bundles)
What this could lead to
If successful, this approach could reduce infections, antibiotic use, and hospital stays for ICU patients.
What could go wrong
This is a single-center, completed study with 120 participants. Results may not apply to other hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Jan 2023

Finished

Apr 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 86 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Length of ICU stay ≥48 hours * receipt of at least one invasive device operation (urinary catheter, ventilator, or central venous catheter \[CVC\]) * age ≥18 years * signed informed consent by the patient or family member (authorized representative for patients with impaired consciousness) Exclusion Criteria: * Presence of DAI at admission; * failure to complete at least one targeted surveillance indicator record during hospitalization * voluntary discharge or loss to follow-up after transfer * combination of severe immunodeficiency diseases (e.g., AIDS, long-term use of immunosuppressants after organ transplantation)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cross infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

nosocomial infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cross infection Equipment and supplies Intensive care units (ICUS) Interdisciplinary communication Nursing care Patient care bundles

Contacts and locations

Locations

  • Qinhuangdao First Hospital

    Qinhuangdao, Hebei, 066000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.